RXRX

RXRX

USD

Recursion Pharmaceuticals Inc. Class A Common Stock

$5.000-0.200 (-3.846%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$5.200

最高

$5.320

最低

$4.970

交易量

57.15M

公司基本面

市值

2.2B

行業

生物科技

國家

United States

交易統計

平均交易量

39.05M

交易所

NMS

貨幣

USD

52週範圍

最低 $3.79當前 $5.000最高 $12.36

相關新聞

GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following

查看更多
Recursion to Participate in Upcoming Investor Conferences
GlobeNewswire

Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th

Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and

查看更多
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
Reuters

Buybacks take backseat as AI drives record US capex spending

Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on.

查看更多
Buybacks take backseat as AI drives record US capex spending